Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid Induced Hyperalgesia with Remifentanil: Gradual Reduction vs Acute Withdrawal
2011-002734-39Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Oct 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remifentanil in opioid-induced hyperalgesia (OIH) and pain (2 arms), sponsored by Oslo University Hospital. Started Oct 2011; status: completed.
02
Drugs
remifentanil
03
Conditions
opioid-induced hyperalgesia (OIH)pain
Beyond the preview
Go deeper on 2011-002734-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002734-39.